Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Morley

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 27, 2009
A simple in vitro assay for assessing the reactivity of nitrile containing compoundsPhilip A MacFaul, Andrew D Morley, James J Crawford
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2Chris De Savi, Andrew D Morley, Ian Nash, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2011
Lead optimisation of pyrazoles as novel FPR1 antagonistsAndrew D Morley, Sarah King, Bryan Roberts, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2011
Discovery of pyrazoles as novel FPR1 antagonistsAndrew D Morley, Andrew Cook, Sarah King, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2009
Novel inhibitors of the alphavbeta3 integrin--lead identification strategyDavid Elliot, Eleanor Henshaw, Philip A MacFaul, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Design of selective Cathepsin inhibitorsPaul A Bethel, Stefan Gerhardt, Emma V Jones, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
5-Aminopyrimidin-2-ylnitriles as cathepsin K inhibitorsAndrew D Morley, Peter W Kenny, Brenda Burton, et al.
Drug Discovery Today|August 3, 2013
Fragment-based hit identification: thinking in 3DAndrew D Morley, Angelo Pugliese, Kristian Birchall, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2011
Selective non zinc binding inhibitors of MMP13Chris De Savi, Andrew D Morley, Attilla Ting, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Structure-based design of protein tyrosine phosphatase-1B inhibitorsEmma Black, Jason Breed, Alexander L Breeze, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|January 27, 2009
A simple in vitro assay for assessing the reactivity of nitrile containing compoundsPhilip A MacFaul, Andrew D Morley, James J Crawford
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2Chris De Savi, Andrew D Morley, Ian Nash, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2011
Lead optimisation of pyrazoles as novel FPR1 antagonistsAndrew D Morley, Sarah King, Bryan Roberts, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2011
Discovery of pyrazoles as novel FPR1 antagonistsAndrew D Morley, Andrew Cook, Sarah King, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2009
Novel inhibitors of the alphavbeta3 integrin--lead identification strategyDavid Elliot, Eleanor Henshaw, Philip A MacFaul, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Design of selective Cathepsin inhibitorsPaul A Bethel, Stefan Gerhardt, Emma V Jones, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
5-Aminopyrimidin-2-ylnitriles as cathepsin K inhibitorsAndrew D Morley, Peter W Kenny, Brenda Burton, et al.
Drug Discovery Today|August 3, 2013
Fragment-based hit identification: thinking in 3DAndrew D Morley, Angelo Pugliese, Kristian Birchall, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2011
Selective non zinc binding inhibitors of MMP13Chris De Savi, Andrew D Morley, Attilla Ting, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Structure-based design of protein tyrosine phosphatase-1B inhibitorsEmma Black, Jason Breed, Alexander L Breeze, et al.
Pageof 2